BIO’s Comments on proposed PTO Humanitarian Technologies and Licensing...
Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System.”...
View ArticleBIO Comments to USTR on 2011 Special 301 Review
BIO Comments to USTR on 2011 Special 301 Review (February 15, 2011) In comments to the U.S. Trade Representative (USTR), BIO stresses the critical importance of protecting intellectual property abroad...
View ArticleBiotech, Gates Foundation, and Global Health
Great interview by Gene Quinn with Erik Iverson, Associate General Counsel with the Bill & Melinda Gates Foundation. A summary article is on BIOtech Now and the full interview can be found on...
View ArticlePodcast: Melinda Moree, CEO of BIO Ventures for Global Health
BIO Ventures for Global Health, together with BIO, is co-host of the upcoming Partnering for Global Health Forum at the BIO International Convention. Moree discusses the Forum and the importance of...
View ArticleIf Biotech Builds…Will Financers Come?
Angie Drakulich from PharmaTech Talk writes: In many countries, it’s easy to get the health minister to understand the value of introducing a vaccine and related healthcare training and therapies to...
View ArticleBiotech addresses food security, climate change: Potential economic growth...
By Jose W. Fernandez, Assistant Secretary of State for Economic, Energy and Business Affairs By 2050, the global population will surpass 9 billion and require nearly a doubling of agricultural output...
View ArticleWhat Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?
The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more than 650,000 direct jobs (supporting a total of nearly 4 million jobs) and an economic...
View ArticleMore Farmers Around the World Plant Biotech Crops
ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record...
View ArticleWhy the Founder of the Anti-GMO Movement Converted to the Side of Science
Mark Lynas is a researcher at the Cornell Alliance for Science and the author, most recently, of “The God Species: How the Planet Can Survive the Age of Humans.” Lynas is a British environmentalist and...
View ArticleOut of Africa: Biomedical Innovation and Expertise
Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden of disease on the world’s populations. Developing countries, such as those in sub-Saharan...
View Article
More Pages to Explore .....